Life Sciences
HIMSS22
Mytonomy’s novel CRM employs high-quality video content to train patients to manage their chronic illnesses, according to CEO and cofounder Anjali Kataria.
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
The collection by Getlabs will cost users a convenience fee starting at $25.
The company, which uses artificial intelligence to make sense of unstructured clinical information like EHR data, raised $18 million in June 2021.
Reify said it will use the investment to focus its tools on increased diversity in clinical trials.
Also: Employer-focused mental health startup Spring Health makes two new hires, and Carrot Fertility adds to its medical team.
Also: RPM company Blue Spark Technologies brought in $40 million in IP-backed debt financing, and Click Therapeutics secured a $15 million loan.
This marks THREAD's third recent acquisition, including the inVibe deal announced early this year and the Modus Outcomes purchase from November.
A new study in The Lancet found that a deep-learning algorithm was able to detect vision-threatening retinopathy with 94.7% accuracy.